Davis Ryman, MD PhD

Davis Ryman, MD PhD has extensive work experience in the pharmaceutical and medical field. Davis is currently serving as the Chief Medical Officer at Aeovian Pharmaceuticals since November 2022. Prior to this, they held the role of Chief Medical Officer at Levo Therapeutics from January 2022 to November 2022 and also served as the Vice President of Clinical Development from June 2018 to January 2022.

Before joining Levo Therapeutics, Dr. Ryman worked as an Executive Medical Director at AveXis, Inc. from April 2017 to June 2018. Davis also held various positions at AbbVie, including Medical Director and Associate Medical Director, Neuroscience Development, from 2014 to 2017.

Dr. Ryman gained research experience as a Clinical Research Fellow at the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) from June 2013 to August 2014. Davis completed their residency in Neurology and internship in Internal Medicine at Barnes-Jewish Hospital from June 2009 to May 2013.

Davis'searlier experiences include working as a Graduate Student Researcher at the Cleveland Clinic from June 2002 to July 2007, a Bioinformatics Scientist at BD Biosciences from July 1999 to July 2000, and a Research Associate at Clontech Laboratories, Inc from July 1998 to July 1999. Davis also served as a Research Assistant for the Drosophila Genome Project at Lawrence Berkeley National Laboratory from May 1997 to July 1998.

Dr. Davis Ryman has an extensive education history, starting with their bachelor's degree in Biochemistry and Molecular Biology from the University of California, Berkeley, which they obtained from 1994 to 1998. After completing their undergraduate studies, they pursued their doctorate in Molecular Genetics at Case Western Reserve University from 2000 to 2007.

During the same time, from 2000 to 2009, Dr. Ryman attended the Case Western Reserve University School of Medicine, where they earned their Doctor of Medicine (M.D.) degree. Notably, they were enrolled in the NIH Medical Scientist Training Program (MSTP), indicating their commitment to both clinical medicine and scientific research.

In terms of additional certifications, Dr. Ryman became board certified in Neurology by the American Board of Psychiatry and Neurology, Inc. in October 2013. This certification highlights their expertise and specialization in this field.

Overall, Dr. Davis Ryman's educational background showcases their strong foundation in Biochemistry and Molecular Biology, complemented by advanced degrees in Molecular Genetics and Medicine. Additionally, their board certification in Neurology further demonstrates their commitment to providing specialized care in the field.